-
Calcium supplementation in women; type 2 diabetes treatments and pancreatitis risk; treating chronic idiopathic urticaria; rivaroxaban and VTE; and FDA actions.
-
Myocardial perfusion imaging (MPI) refers to the utilization of radiotracers to image regional myocardial perfusion from coronary artery blood flow to the heart muscle. Used effectively, MPI can provide the clinician with a noninvasive technique that yields both important diagnostic and powerful prognostic information regarding the functional significance of anatomic coronary artery disease. MPI can help guide therapeutic decision-making by stratifying patients with respect to future risk for adverse outcomes.
-
In this issue: Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.
-
In this study, the authors sought to elicit perceptions of the impact of a rapid response team (RRT) by interviewing care providers.
-
-
Fagan and colleagues at Denver Health Medical Center examined electronic data collected on all adult patients who generated a medical surgical acute-care room charge during a recent 6-month period and remained on the ward for at least 24 hours.
-
This study conducted in five ICUs at two academic hospitals in San Francisco sought to describe how comfort care is presented to surrogates and if physicians beliefs on whether life support should be withdrawn are associated with the option of comfort care being presented.
-
Nutritional support is an essential component of caring for critically ill patients.
-
In an apparent attempt to err on the side of patient safety, advisors for the Centers for Disease Control and Prevention made recommendations for influenza vaccination of health care personnel (HCP) that went beyond the scientific evidence and now are the source of mandatory and punitive policies, the Center for Infectious Disease Research & Policy (CIDRAP) charges.
-
Recognizing their common stake in preserving antibiotics, a diverse collaboration of more than a dozen groups -- including the Centers for Disease Control and Prevention, the Association for Professionals in Infection Control and Epidemiology, the Infectious Disease Society of America and the Society for Healthcare Epidemiology of America recently joined in a partnership that began with the issuance of the following joint statement: